A signature of enhanced proliferation associated with response and survival to anti-PD-L1 therapy in early-stage non-small cell lung cancer.

Cell Rep Med · 2024 · PMC10982989 · PMID 38401548

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not achieve significanceno p-value reported

In addition, metabolic and signaling pathways related to rapid proliferation are enriched in the MPR group, although they did not achieve significance at FDR < 0.05.

also in 1,397 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.